Clinical Trials – Active Research for MS

This year has been an active one for clinical trials focused on treatment for multiple sclerosis. Some treatments are very close to receiving approval from the FDA or other decision-making organization, while others are many years away but still offer hope of new therapies. The time until approval can generally be determined by the phase of clinical trial that the treatment is in. Some of the treatments that are currently in clinical trial are:

Fingolimod – Phase 3

Fampridine – Phase 3

Cladribine – Phase 3

MBP8298 – Phase 2-3

Sativex – Approved in Canada, Final in Europe

Campath – Phase 2

Neurovax – Phase 1-2

http://ms.about.com/b/a/257728.htm?nl=1